“Elixir”DynamX Novolimus Eluting Coronary Bioadaptor System - Taiwan Registration ff5ecc6613b72eaa8871e0d607bca591

Access comprehensive regulatory information for “Elixir”DynamX Novolimus Eluting Coronary Bioadaptor System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number ff5ecc6613b72eaa8871e0d607bca591 and manufactured by Elixir Medical Corporation;;Acon Regulatory Consultancy Services Ltd. The authorized representative in Taiwan is CLOVERS BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.